41，Sato T,Kawamoto A,TamuraA et al..Mechanism of antioxidant action of pueraria glycoside(PG)-1(an isoflavonoid) andmangiferin(a xanthonoid).Chem Pharm Bull Tokyo，1992,40:721.
55，Behan W M,Mc Donald M et al..Oxidative stress as a mechanism for quinolinicacid-induced hippocampal damage:protection by melatonin and deprenyl.Br JPharmacol,1999,128:1754.
66，Rosler M,Retz W,Thome J et al..Free radicals in Alzhe-imer's dementia:currently available therapeutic strategies.J Neural TransmSuppl,1998,54:211.
77，Richards J G,Saura J,Luque J M et al..Monoamine oxidase:from brain maps to physiologyand transgenics to pathophysiology.J Neural Transm Suppl.1998,52:173.
88，Burke W J,Kristal B S,Yu B P et al..Norepinephrine transmitter metabolite generatesfree radicals and activates mitochondrial permeability transition:a mechanism forDOPEGAL-induced apoptosis.Brain Res,1998,787:328.
99，Alper G,Girgin F K,Ozgonul M et al..MAO inhibitors and oxidant stress in aging braintissue.Eur Neuropsychopharmacol,1999,9:247.
1010，Aubin N,Curet O,Deffois A et al..Aspirin and salicylate protect against MPTP-induceddopamine depletion in mice.J Neurochem,1998,71:1635.
